Although many proteases exist in human placenta, their physiologic roles are still unknown. Our study showed that placental proteases metabolize vasoactive peptides possibly derived from the fetus.
Because vasspressin and angiotensin are known to play an important role in normal and aberrant I preeclampsia) fetal-placental circulation, the clearance of these peptides in the placenta is important in controlling fetal bled pressure. Vasopressin and angiotensin act as a fetalplacental vasuconstrictor; therefore, placenkl proteases in human placenta are likely to wcrk as G clearance factor for these peptides.
Although human iand animal pregnancy is normally associated with a refractory response to rhe pressor effect of exogenously infused angiotensin II, patients with preeclampsia, as well as nonpregnant women, are sensitive to the pressor effect of angiotensin Il. Our study suggested that the decreased pressor responsiveness Lo angiotensin II in pregnancy is caused by increased inactivation of angiotensin II by angiotensinasr in pregnant serum and the placenta.
Al though vasopressinase and angiotensinase activities increase with advancing gestation in normal pregnant sera, the activities of both enzymes in severe preeclampsia sera were clearly lower th3!1 those in normal pregnancy. Therefore, it is reasonable to speculatr! that the increased sensitivity tc angiotensin II of preeclampsia is Gitributable to the decreased degradation of angiotensin II by placental angiotensinase.
The negative correlations between the systolic to diastolic ratio obtained from pulsed Doppler measurement techniques and the activities of both enzymes in preeclampsia sera suggested that the systolic to diastolic ratio, :vhich reflected co;lstriction cf placental vessels, is influenced by the concer&ration of vasoactive peptides in the fetaI-placental circulation due to changes in the activities of placental qroteases.
Placental proteases play important roles in controlling fetal and maternal blood pressure through regulation of the concentration of vnsoactive peptides in the interface I placenta 1 be!.ween fetus and mother. Am J Hypertens 1996; 9:591-597 KEY WORDS: Angipjteiwinase, vasopressinase, placental leucine aminopeptidase (P-LAP 1, preeclampsia, utr!ro~:Iaccntal circulation, refractoriness to angiotensin II.
--.-I n IL)39 Goldblatt et al observed that hypertrnsivtl ser\xtion suggests tkti pregnancy is beneficial for hydogs, with the advancement of pregnancy, show prkrlsion, pregnancy is frequently complicakd .Nith a t!ecrease in blood gwssuw. Although this ob-a hypertensive dismaer pculiar ta pregnancy (i?, Tu date we have con?uct?cl 115 years of research and published several paper:. 6:~ placental proteases, which metabolize vasoactiv: peptidzs, possibly derived from the fetus, and protect the exchange of ptptide hormones X;OSS the placenta tn maintain fetoplacental homvostasis. Our data haVe suggested that the placentai prflte,i5i's play important roles in controlling f~tnl rind maternal blt)od pressure in nclrma1 pregnancy and pre~~clampsia-Preeclamysia, which usually i:pptlars nfter the> 20th gestational week, and most frequently near term, is characterized by proteinurja, edema, and at times coagulation abnormalities. When the c!i~ease progresses to a conclusive phase it is termed eclampsia. Hypertension in pregnancy is confusing, largely because it is often difficult to distinguish clinically between pre~clampsia, c5sential or srctxdary l,ypcrtcnsion, renal disease, and combinationc of thcsc seDi.l<iiti I ntities. More ihnn academic interest requires rllat I-ypertensiren during pregnancy be cstegorjzed correctly; the mnnagemcnt of both the hy,wxtension and the pregnarrry, as weli as t!x p w g nosis ior future pregnancies, varies with the diagnosis. To approach these problems, an understanding of the placental protease!, in normal and abnormal pregnancy is illirlcsti:g ;;_I;? important. WC wilt show how WC hJve come to .he above conclusion by citing rtTtt:vant literatl.lre and data.
BLOGD PRESSURE CONTROL FACTORS the utcrt,placcntnI circuhtion. FtntaI bled flows to the umtli~ical-placentaI circulation, anJ maternal blood tl~ws to the retroplacental (mixed arterial and venous blood between the inner uterine wall and the placenta) bi, od pc~111. This special organ, the placenta, is considered to have ;lr. important role in maternal and fetal blood pressure control during pregnancy (Figure 1 I. Let us then consider the physiology of how the intrinsic polarity of the placenta could regulate maternal and fetal circulahns indeptndently. We found nine proteases in human placenta and in the blood of the pregnant woman and examined the metabolism and degradation of vasoactivc peptides such as angiotensin and bradykinin.' In this review we referred to the ;Ingintensinase and vasopressinase that were suggested by Werlu and Page, respectively. The structure of vasopressin and angiotensin II and the site of cleavage? by vasopressinasc and angiotensiriase are shown in Figure 2 A,R. Vasupressinase and angiotensinase in pregnancy sera arc identical to pregnancy sera cysteine aminopeptidase (EC 3.4.11.31 , that is, placental Ieucine aminopeptidase (P-LAP)"" and aminoprptidasc A CAP-A, EC 3.4.11.7),h,7 respectively, which increasewith advdncinggestatian(Figure2C).
Molecular cloning, also showed that AP-A is identical to the cell surface glycuproth (gp 160) .B Recently we have isolated a cDNA clone with 4034 base pairs encoding P-LAP from the hxnan placental cDNA library. The amino acid sequence deduced from the cDNA conCq;*r~ !?I? ~JFYXY,ci,n:;cn~us seqtiencc of zinc-metallo-.s..*.._ peptidase, indica.ing that P-LAP belongs to the family of zinc-rr,erallr?~Pptidases, which include!; aminopeptidase N (EC X4.11.2) and 41)-A. In addition, Northcm blot analyst 'I, sh<bwt*d the distributicjn of P-LAP 11ot crnlv in thta hrrman placenta but also in the human brain.' a on plrtcenta'. ce'ilular membranes, v,hich come in contact with one elf the circulations, and should bSx distinguished from the concentration of vasoactive peptides in the materna: or fetal circulafion. Devane and Porter"' studied the vasopressin le',lels in umbilical arterial and venous b!ood and matcrnJ1 vencus blood in norma! and stressed vagir,;:l delivery in humans. These data showed that the leS/els in both umbilical arterial ar.d venous olood lucre higher than those in maternal blood, and the levels in umbilica! arterial blood were also much higher than those in umbilicai venous blood in both deliveries. In addit]&-n, t!re data showed a greater level of difference between umbilicdl arterial and venous blood in the stressed &Iivrry, *!!ich suggcstet-i an increased vasopressin release fro.n the strJJl,ssed fetus and a decreased degradation by the placc~t::l vasopressinas+:.
Brough.ton-'Pipkin and Symrmd " compared the level of rrngiotensin 11 in rmbilk~l artttrinl nnd V~WCUIS blood and maternal vt'ntrus bltlod in nt;r.,nal pregnancy and preecldmpsia. 'The data showed ,hat the level in umbilical W~ICWS 11l~d was higher than that in umbilical arterial blood in both normal pregnancy iltld prcVcl;lmpsia, and the levels in both umbilical venous blood llnd maternal venous blood in cases of severe preectampsia were al50 milch higher than those of normal pregnancy. The gradient of angiottlnsin II between umbilical venous and arterial blood suggests the active involvement of placental ACE in angiotensin II production in the fecopiacental unit. In addition, their data showed a greater level of difference between umbilical venous and arterial blood in cases of preeclampsia. which suggested an increased angiotensin releast! irom the stressd or transiently hypuxrmic fetus and a decreased degradation by the placental angiotcnsinase. We found ACE in human placenta, which generates angiotensin II from ansiotensin I, "v" and showed that maternal serum ACE activities ciiG not change in preeclampsia compared with normal pregnancy." For the human placenta the maximum size of molecults that could transfer acrc~s the placenta wwuld be 5 to 7 kD. Tht-sizr of vasllxtive peptides such as angiotensin and vasopressin are around 1 kD. The difference in concentrations of the vasoactive peptides Between the fetus and the mother results in an understanding of degradation by placental proceases. If the rate of degradation of vasoactive pepti&3 oy placental proteases is greater thaiI the rate of trzrsfer across the placenta, then this process would facilitfite independent regulation of the maternal and fetal circulations.
FETAL BLOOD ClRCULATION
I: is well known that fetal blood pressure is low, betwesn 40 and 50 mm Fig. Pldcentai circulatiun is 40% ta 50% of the fetal-placenta1 circulation at late pregnancy and considered to have a strong influence ~11 f&a1 blood pressure.lS A series of investigations on physiologic and Fharmacologic f&al-placental cirrulation factor; h;~, &~'n conducted in sheep. The relation Mween ferntIm artery prrssu.-e of the ft3us and placental bloorI flow was stutiied after clamping the descending aorta of t.he sheep fetus.'" ,4 positive correIation was found berwecr, placenta!. blood flov: and fetal blood pressure, indicating that there is little autoregulation of placental blood flow.
Let us thrzn cornpaLe the influence oi thr mtunl>-mous nervous system and the humoral factors. Angiotensin II is a strong vasuconstriz!il*n peptide, and norepjneph:ine is also a strcq vasoconstriction factor that acts a~ a postganglionic adrenergic mediator. Clark et al'? compared the inf'hlence nf norepinephrine an& ;jllbiotcnsin II on the regulation of placental circulatior:. When these two types of vessel-constricting j..lctors were given to the sheep fetlrs, they founrj th:ii 'mgiotensin II reduced thp blood flow of umbilical i'!:ssttls and increased the wssul rusistdnce. On thr:, ct).:trary, ncrepinephrine had almost no effect on ei timer.
Thaw results strongly indicate that the main reguIntins iactor of placental circuIztion is thr humoral factor, not autoregulation or the a::tsn;,iilic nervuus NO. 6 system. Vasoprk*ssin is a ptlptidr that eftccts ~rstric-titan of thz artt'riolty and raises bloud prC";s;L:re V~SIJ-presssin is called an antidiuretic hormone because it also effects waker retention. If we leave a pregnant sheep under a low oxygen condition, its fetirs quirk1 i increaws vasopressin secretion." Altho@ it is unlikely tl;at vasopressin exerts a ton;c influence cm the normai fetal circulation, " its release may play an important role in the fetal cardiovascular response to stres5.z" The effects of the infusion of angiotensin 11"J2' and the reduction of its cffrcts by the drug saralssin" in the shwy fthtus suggest that angiotensi6 II plavs an importan; role in providing adequate blood tt& to the placenta in the normal fetal cnrdiovdr;cular Fhysil,lo):~ ind could play a role in aberrant conditions in trhirs-,~!accntal circulation. Kingdom et al" inwsti--at4 the relation between umbilical arterial oxygen b par:i,a: pwure and angiotensin II levels in the umbilic.11 i,'.,-d;;iF,:;; human delivery. They found that if thrm numan fetus suffered from a low oxygen levrnl caused by stress, the level of angiotensin 11 in the um:Jilical irein was high. This indicates that, as in the sheep fetus, under conditions of stress the angiotensin 11 level will go up in the human fetus.
Maigaard et al-' irdministered physiologic doses of nngiotensin It and vasopressin to placental vessel5 in vitro and annlyzcd vasnconstriction. They found iilai both angic:errsin 11 and vasopressin tightly constricted the placer,tal vessels. When a pregnant sheep is under a condi --of low oxygen, the blood flow incren:ics to orl;a:,s essential for life tie, placenta and brain) nnit decrmsus to other orgar:.s. 'This is called redistribuLon of blood flow and is w4l known as an adaptive phenomenon of fetal circulation to the condition of stress.'" Umbilical-placerltal blood flow, Mphich has n signitkant intluence on fetal blood pressure, is regulated mninly by the v,~~~~~~~~~~trict~l~~ ~c'ytidcs, whir-h nr, prtrduccd by thlb fthtllq 'n*'uz' III spite of the incrra$e in setmtion of the KMY'O' .,Arictilq peptidvs under conditions of stress, thk* blor)J 90~ to the placenta increases, z"~'?l' strongly indicating thut tlxrc most btla mcchnnrsm that keeps the placental bluoci vessels from constricting, even in the presence of i:lcreas;ed levels of vasoconstriciing peptides. Brcause angi&en-sin II and tiasopressin act as a fetal placental v'sc'constrictur both in vivo and in vitro, the fact that i5is redistribution occurs must bs bocausc these -as<;-active pttlltidtls have r4ati:bely less efftzct on placcntiil (brain) vascular re4+lancc than 011 the resistance of othr beds. There is r-ttrent research that shows that ttwrc is 3 very I;lrgc clearance of vasoactjve peptides Xrt)S5 thl! fetal placental Cjrcuj,~tion,'7," which rr.n~ support our hypothesis. There is also a very large in-~:t~as~ in the blood prtn?sure of the nt'la:bs.,rn in the wctk following birth."' It is pussiblc that the disapyenrnnctt ot placental prllt(:nsr*s caatribute to this incre'ase in blood prcssurr..
MATERNAL BLOOD PRESSURE
Thr changes in the level of angiotensinase and vasopressinase m the blood of the normal pregnant human is shown in Figure ZC . Proteases increase with an increase of the placental weight. We started to measure the level of i!scental proteases in maternal bid as a functional te(:t of placenta 25 years ago on the basis of recognition tat placental proteases become scluble ln the blood L'; rhe pregnant woman. It is well knc wn that if we administer angiotensin II to a noqpregnant woman or rat the blood pressure goes up, 3L-32 whereas the senslli v ;ty to angirlttinsm II of normal pregnant women or pregnant rats is much lowrr. According to the study of Cant et al" on normal pregnant women, the dose of angiotensin II necessary to increase diastolic blood pressu:e by 2'7 mm Hg starts to increase from the 10th week of pregnancy. It reaches a mnximum at around the 30th wmk of I" .*':x;nqnr,v .4t the 3Uth week of pregnancy apgroximately two and half times as much dosage is required to increase the blood pressure by 20 mm Hg as in nonpregn; nt womcn ( Figure 38 ).
If we give human Lllacental angiotensinase to the high blood pressure rat, induced by continuous infusion of angiotensin !I, the placental angioteajinase bra*bc down angiotensin 11 in vivo, and t!re blood -I -Wm._ pressure of the rat goes down."' In addition, we showed the ability of human placental AP-A to decrease the blond pressure of spontaneously hypertensive rats tSHR)." Administration of ACE inhibitor nrjrmalizus the blood pressure of SHR, suggesting a possible role of the renin-angintensin system in the eltavattld birlod pressure of SHR."' Because angic;tensinase activity is high in the biood of the pregnant woman,' the characteristic decrease in swb.ILvlty to the extraneous aneintPn+ in !hG ,lucmal pregnant wc,:nan,"' . 1s suggested to be effected by increased placfw tal angiotensinase.52-" When we gave bestatin, the sel;'ctivt' inhibitor of angiotensinase (AI'-A),"" to the pregnant rat, which also showed a decrease in sensitivity to angiotensin II, it became a:; scnsitivc ;1s nonpregnant rats." Accordingly :Z;l:re is a close relationship between placenta! anf;iotcn:;insse and sensitivity to angiotensin II in the pregnant woman.
PREECLAMPSIA AND PLACENTAL PROTEASES
Next we discuss precr-!ampsia, iir, abnormality in the rrrntrol of maternal-ft!tal blood prrssure and placental prote,;s!:r, SiYnrltaneous Pl~JS~ir~ll~~lIt of IYliltkXii.ll serum vast)yrrssin;lsd (P-LAP) and angiotensinase (AI'-A) in o-Jr prosptictive study showed differences in their activities around the nnsct of prr~cclnmpsia.~ P-LAP x:;vi t1tlr; in prcpna;lt wimlcn, wl10 subsclque'ntly developc4 mild pre~clampsi~~, we're higher than those in normal pregnant rvumrn broth bcfure and dfttir the appearance of niId ptceclar.rpsia. We ;11so found interesting patterns of changes in the P-LAP of patients with preeclamrqia. Serial measurements of P-LAP activity in patients, who event-Jally developed severe preeclampsia, showed a rrlaximum level at week 31, where tile values were significantly higher than in normal pregnancy, and at that stage patients were already mildly preeclamptic. After week 35, the activity decreased sharply to week 40, and the activity ir. patients wiih severe preeclampsia during weeks 39 and 40 was much weaker than in normaI prcgnatq (Figure 4) .37
AP-A activities after the appearance ni' precdarnpsia were also higher than those in normal pregnancy in uur prospective strldy:* However. AI'-A activify i-y pret*clnmy:;ia dt creased in relation t;, the Leveret: vss ot the preeclampsia. ' We found r7 prallel increase in P-LAP and lil' :J after the appt'tirawr~ nf preccidmpsin in our prospective strldy..U tihat is the meaning of the increase ir. I'-I.Ai' and the parallel increases in P-LAP and AP-A, before and just after the appearance of preeclampsia, respectively? Recrsnt studies have shown that al\giotensin II plays an important role in normal and aberrant conditions in fetoplacental circulation, whereas vasopressin plays an imr;ortant role in the fetal cardiovascular response to stl~ss. It is interesting to speculate that the increases in tht: activities of both proteases in matl*rnal sera might counteract the increased fetal secretion ot vasoactive peptides in response ta stress. Because the levels of maternal serum P-LAP and AP-A might reflect the production rate in the placenta, the decreased serum proteases in Sclvere preeclampsia suggest an increase in placental vascular resistance by both the increased fetal secretion rd vasoactive yiptides and the decrus4 degradation of vasoactivc peytides in the preecla.mpsia placenta. In studies by Gant et al" comparing sensitivities to angiotensin 11 during pregnancy between normal and przeciampsia patients, the sensitivity of !he qreeclampsia patients becomes higher, reaching a level of sensitivity equivalent to that of the nonpregnant vroman Il-lgurtl 3E). Even in low concentration, angiotrrnsin II in the blood of preeclampsia patients works as a factor to increase the blcocl pressure. Tblis can be explained if we consider the decrease In serum angiotensinase activity in yreeclampsia patients ( Figure 3A ) . ' The data on the relationship between maternal angiotensin II concentrrltion and blood pressure in preeciampsid is now in dispute. Some reseljrchcrs have It is Impossible to measure th? fetal blti ~;re~sur~ directly. However, the pulsed appler method ha5 made assessment of bloc,l floti-ve!ocity possible and is now widely used to monitor uteroplacental blood flow.% The S/D value, the ratio of the blood flow W&C-ity of the systolic (S) and the diastoilc ! D) stages, cbtained from the pulsed Doppler method shows the re sistance of peripheral vessels. The S/ D ratio :hows a low value when the resistance of the vessels is low. The factors that regulate the resistarce of the peripheral vessels are the degree of vessel constriction and the total volume of the vessels. During nsrmal pregnancy the SiD ratio of the umbilical artery decreases with the advancement of pregnancy. There are many factors that influence the decrease in the S/D ratio during normal prwancy. The increase in the vascular bed that accompAni-the growth of the fetoplacental volume and the very large clearance of angiotensin 11 and vasopressin by placental protease?; across the fetal placental circulation are important amting them.
When we comparti the correlation of the enzyme activities of angiotensinase / vasopressinase with the S / D ratio of the un?bilical artery in the preeclampsia patients, there were neg,>tive correlations between the S/ D ratio and both enzymes?9 These negative correlations were consider4 to occur as a result cf the increase in the S / D ratio, t*.lhich reG&d constriction of placental vessels. It cculd I>e concluded that because of the decrease ir, the activity oi placental proteases in the preeclampsia patients, the vasoatiive peptides, angiotensin II and vasupressin, could not be broken down, resulting in the constriction of placental vessels and the increase in the S/ D ratio. When preeclanpsia worsens, the activitiies of the placental proteases decrease; the decrease in the capaci;y to break down excess peptides, the resulting decrease of vasoactive peptides clearance, and the increase in tilti sensitivity to the vzsoactive peptides in the fetoplacental circulation are rsults.
COPU'CLUSIONS AND S1IGGESTIONS
Accordingly, the functional intactness, including protease production of the placenta, which exists at the interface between mother and fetus, is vital to maintenance of the homeostasis of maternal-fetal blood pressure. When we think about the action Df hormnnes, we usually think about their production, secretion, and level in the blued. During pregnancy fetal hormone secretIon increases exponentially Xcording to fetal growth. The change in hormone level is very dynamic during pregnancy.
The clearance factors would ulav a vex-v imDortant role. eswciallv in such ccnditions. Needless to say, the existence of sub stances depends on both production and breakdown.
The contribution of placental proteases in the pa thophysiolc my of prqilancy should be given more sariocs evaiuation ap.d be further clarified. We would like lo emphasize that one can correctly understand the ar:tion ;lf hormones only when both productinn and h.radkdown are taken into account. c/-4 ACKNOWLEDGMENTS by-xc ,-rateful to Ur. I-f. Nakatato (suntory lnstitb!e for biomedi&.l
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